VanEck Morningstar Wide Moat ETF (MOAT) is an exchange-traded fund that seeks to replicate the performance of the Morningstar Wide Moat Focus Index, targeting U.S. companies with sustainable competitive advantages, or "wide moats," trading at attractive valuations relative to Morningstar's fair value estimates; the portfolio emphasizes sectors such as health care, industrials, information technology, and consumer staples, with top holdings including Applied Materials Inc., Estee Lauder Cos. Inc., Huntington Ingalls Industries Inc., Thermo Fisher Scientific Inc., and Merck & Co. Inc.. MOAT provides investors with exposure to approximately 54 holdings, primarily large- and mid-cap U.S. equities (97% U.S.-domiciled), supplemented by minor non-U.S. positions like NXP Semiconductors N.V. in the Netherlands; it features a net expense ratio of 0.47%, daily liquidity on the Cboe BZX Exchange, and options trading availability.. Launched on April 24, 2012, and domiciled in the United States, the ETF is managed by VanEck and leverages Morningstar's equity research from over 100 global analysts.. In recent developments, VanEck expanded its moat-focused product suite in March 2024 with the launches of the VanEck Morningstar Wide Moat Value ETF (MVAL) and VanEck Morningstar Wide Moat Growth ETF (MGRO), complementing MOAT alongside related offerings like the Morningstar Global Wide Moat ETF (MOTG) and Morningstar International Moat ETF (MOTI); additionally, in September 2025, VanEck announced the liquidation of underperforming moat-related ETFs including the Morningstar ESG Moat ETF (MOTE) and MGRO based on factors such as assets under management and investor interest.. As of December 2025, MOAT manages total net assets exceeding $12.9 billion, reflecting strong investor demand for its quality-focused, value-oriented U.S. equity strategy..